Multicenter Study to Evaluate CRx-102 vs. Each of Its Components to Treat Active Rheumatoid Arthritis

NCT00551707 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: CRx-102 (2.7/180)
DRUG: prednisolone
DRUG: dipyridamole
DRUG: placebo
DRUG: CRx-102 (2.7/360)

Sponsor

Zalicus